APR 08, 2015 9:16 AM PDT

Turbo-Charging Hormone Can Regrow the Heart

WRITTEN BY: Judy O'Rourke
Researchers have discovered a way to stimulate muscle regrowth in the heart of a mouse, opening up prospects of new treatments for many who suffer heart attacks each year.

The animal study found it was possible to regenerate muscle cell numbers in the heart by up to 45 percent by ‘turbo-charging' a hormone that helped coordinate cell growth.

According to study lead author, associate professor Richard Harvey, PhD, UNSW, based at the Victor Chang Cardiac Research Institute, New South Wales, Australia, this is an important step toward repairing a broken heart.

"Unlike blood, hair, or skin cells, which can renew themselves throughout life, cell division in the heart virtually comes to a standstill shortly after birth, which means the heart can't fully regenerate if it is damaged later in life," Harvey says.

"Previous studies have demonstrated that it is possible to coax heart muscle cells to proliferate again, but only at very trivial levels," he says. "What the research team has been able to do is boost heart muscle cell numbers by as much as 45 percent after a heart attack."

The scientists focused on a signalling system in the heart driven by a hormone called ‘neuregulin'.

By switching the neuregulin pathway to ‘turbo charge', the researchers found that heart muscle cells continued to divide in a spectacular way in both the adolescent and adult periods. Stimulating the neuregulin pathway during a heart attack led to replacement of lost muscle.

"This big achievement will focus the attention of the field on heart muscle cell replacement as a therapeutic option for ischemic heart disease," Harvey says. "The dream is that one day we will be able to regenerate damaged heart tissue, much like a salamander can regrow a new limb if it is bitten off by a predator. Just imagine if the heart could learn to regrow and heal itself. That would be the ultimate prize."

The research, conducted at the Weizmann Institute of Science in collaboration with the Victor Chang Cardiac Research Institute, and titled "ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation," is published in Nature Cell Biology.

[Source: UNSW]
About the Author
  • Judy O'Rourke worked as a newspaper reporter before becoming chief editor of Clinical Lab Products magazine. As a freelance writer today, she is interested in finding the story behind the latest developments in medicine and science, and in learning what lies ahead.
You May Also Like
MAY 03, 2021
Cardiology
Task Force IDs 7 Costly Medical Procedures With No Benefit
MAY 03, 2021
Task Force IDs 7 Costly Medical Procedures With No Benefit
Researchers have identified a surprising number of health screens that are given to patients who may not need them. Thes ...
JUN 07, 2021
Cardiology
Researchers Find a Way to Improve Outcomes After a Heart Attack
JUN 07, 2021
Researchers Find a Way to Improve Outcomes After a Heart Attack
It's thought that in the United States, there is a heart attack once every 40 seconds, or that each year, about 80,0 ...
AUG 03, 2021
Health & Medicine
Viruses and Autoimmunity: What Pandemics Have Taught Us
AUG 03, 2021
Viruses and Autoimmunity: What Pandemics Have Taught Us
COVID-19 infections have given rise to COVID long haulers, people who had COVID and continue to have symptoms months aft ...
SEP 01, 2021
Technology
Keep 6 Inches Away: Smartphones and Watches Can Interfere With Implanted Medical Devices
SEP 01, 2021
Keep 6 Inches Away: Smartphones and Watches Can Interfere With Implanted Medical Devices
Recent guidance by the U.S Food and Drug Administration (FDA) recommended that people with implanted medical devices sho ...
OCT 27, 2021
Cardiology
Are Certain Anti-inflammatory Agents an Effective Treatment for Heart Disease?
OCT 27, 2021
Are Certain Anti-inflammatory Agents an Effective Treatment for Heart Disease?
Worldwide, heart disease is responsible for millions of deaths and, in the US, is the most common cause of death de ...
NOV 19, 2021
Technology
Artificial Intelligence Could Predict Risk of Atrial Fibrillation
NOV 19, 2021
Artificial Intelligence Could Predict Risk of Atrial Fibrillation
Atrial fibrillation (AF) is a common heart condition—by 2030, the Centers for Disease Control estimates that nearl ...
Loading Comments...